Lv2
190 积分 2025-02-28 加入
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
1个月前
已完结
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
2个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
5个月前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
5个月前
已完结
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
5个月前
已完结
Rational design of a GLP-1/GIP/Gcg receptor triagonist to correct hyperglycemia, obesity and diabetic nephropathy in rodent animals
8个月前
已完结
阻塞性睡眠呼吸暂停低通气综合征诊断和外科治疗指南
8个月前
已完结
Tirzepatide Once Weekly for the Treatment of Obesity
8个月前
已完结
Rational design of a GLP-1/GIP/Gcg receptor triagonist to correct hyperglycemia, obesity and diabetic nephropathy in rodent animals
9个月前
已完结
Current perspectives on the use of GLP-1 receptor agonists in obesity-related obstructive sleep apnea: a narrative review
9个月前
已完结
皖公网安备34019202002308
